Holen Sie sich die Stockscreener-App
532.00
2.14%
11.13
Handel nachbörslich:
532.00
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$520.87
Offen:
$523.05
24-Stunden-Volumen:
569.89K
Relative Volume:
0.93
Marktkapitalisierung:
$42.78B
Einnahmen:
$3.93B
Nettoeinkommen (Verlust:
$894.97M
KGV:
49.17
EPS:
10.82
Netto-Cashflow:
$837.70M
1W Leistung:
+1.01%
1M Leistung:
+1.54%
6M Leistung:
+23.55%
1J Leistung:
+11.93%
1-Tages-Spanne:
$520.16
$533.47
1-Wochen-Bereich:
$506.91
$533.47
52-Wochen-Spanne:
$356.14
$549.52
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional
What drives IDEXX Laboratories Inc. stock priceRapid growth trajectories - jammulinksnews.com
What analysts say about IDEXX Laboratories Inc. stockUnmatched profit growth - jammulinksnews.com
Should You Consider Adding IDEXX Laboratories (IDXX) to Your Portfolio? - Yahoo Finance
Is IDEXX Laboratories Inc. a good long term investmentUnprecedented growth rates - jammulinksnews.com
IDEXX Laboratories Inc. Surges to 413th in Trading Volume with $253 Million in Shares Traded - AInvest
Here's What to Expect From IDEXX Laboratories' Next Earnings Report - MSN
Agree To Buy Idexx Laboratories At $490, Earn 9.8% Annualized Using Options - Nasdaq
Leerink Partners Forecasts Strong Price Appreciation for IDEXX Laboratories (NASDAQ:IDXX) Stock - MarketBeat
How high can IDEXX Laboratories Inc. stock price go in 20253x Return Stock Radar - beatles.ru
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $600 - 富途牛牛
Expert Outlook: IDEXX Laboratories Through The Eyes Of 6 Analysts - 富途牛牛
**IDEXX Laboratories: A High-Quality Business with Strong Fundamentals and Attractive Long-Term Growth Prospects** - AInvest
IDEXX Laboratories, Inc.: A Business With Very Strong Fundamentals (NASDAQ:IDXX) - Seeking Alpha
Idexx Laboratories (IDXX) Sees Raised Price Target from Leerink Analyst | IDXX Stock News - GuruFocus
Are Robust Financials Driving The Recent Rally In IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock? - 富途牛牛
Here's What To Expect From IDEXX Laboratories' Next Earnings Report - Barchart.com
IDEXX Laboratories Expands Board with New Director - The Globe and Mail
IDEXX Laboratories (IDXX) Announces Election of New Independent Director - GuruFocus
IDEXX Laboratories Appoints Joseph L. (Jay) Hooley To Board - citybiz
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors - AInvest
STOK files 8-K; releases data guiding Phase 3 EMPEROR dosing | IDXX SEC FilingForm 8-K - Stock Titan
What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Yahoo Finance
Here's How Much You'd Have If You Invested $1000 in Idexx Laboratories a Decade Ago - Yahoo Finance
IDEXX Laboratories Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - simplywall.st
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years - Benzinga
Stifel Nicolaus Issues Positive Forecast for IDEXX Laboratories (NASDAQ:IDXX) Stock Price - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
Idexx Laboratories stock hits 52-week high at $546.61 By Investing.com - Investing.com South Africa
Idexx Laboratories stock hits 52-week high at $546.61 - Investing.com
IDEXX Laboratories (IDXX) Price Target Raised by Stifel | IDXX Stock News - GuruFocus
(PDF) Performance comparison of SNAP® 4Dx® plus and AccuPlex®4 for the detection of antibodies to Borrelia burgdorferi and Anaplasma phagocytophilum - researchgate.net
Stifel Adjusts Price Target on IDEXX Laboratories to $540 From $510, Maintains Hold Rating - MarketScreener
Investing in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Would Have Delivered You a 58% Gain - 富途牛牛
IDEXX Laboratories, Inc.(NasdaqGS: IDXX) dropped from Russell 1000 Dynamic Index - MarketScreener
(PDF) Validation of immune complex dissociation methods for use with heartworm antigen tests - researchgate.net
What Makes IDEXX Laboratories (IDXX) a Good Investment? - Insider Monkey
IDEXX Laboratories to Release 2025 Second Quarter Financial Results | IDXX Stock News - GuruFocus
Idexx Laboratories stock hits 52-week high at $530.74 - Investing.com
IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners - Insider Monkey
12 Best Healthcare Stocks to Buy Now - Insider Monkey
IDEXX Laboratories Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
IDEXX Laboratories (IDXX) Sees Price Target Raised by Leerink Pa - GuruFocus
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):